NY-338

N/A

Report date: 2025/01/08 16:56:19

Base Information

Drug NameNY-338
Drug Alias NameCYT-338NY-338
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionNatural killer cells stimulantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsNatural cytotoxicity triggering receptor 1 agonists +[4] 
TargetsNatural cytotoxicity triggering receptor 1Lymphocyte differentiation antigen CD38
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCytovia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNAYA Biosciences IncCytovia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A